Dch Rapid Relief Hemorrhoidal Spray
NDC Package 72839-263-05

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Dch Rapid Relief Hemorrhoidal (lidocaine 5%, phenylephrine hydrochloride 0.25%) sprays is helps relieve the local itching and discomfort associated with anorectal disorders or inflammation. This formulation utilizes a spray delivery system. Marketed by Derma Care Research Labs, this product is identified by NDC 72839-263 and is authorized under FDA application M015.

Identification & Billing

NDC Package Code
72839-263-05
Package Description
142 g in 1 CAN
Product Code
72839-263
11-Digit Billing Format
72839026305
RxNorm Crosswalk
  • RxCUI: 2590656 - lidocaine 5 % / phenylephrine hydrochloride 0.25 % Rectal Spray
  • RxCUI: 2590656 - lidocaine 50 MG/ML / phenylephrine hydrochloride 2.5 MG/ML Rectal Spray

Clinical Specifications

Proprietary Name
Dch Rapid Relief Hemorrhoidal
Non-Proprietary Name
Lidocaine 5%, Phenylephrine Hydrochloride 0.25%
Substance Name
Lidocaine; Phenylephrine Hydrochloride
Dosage Form
Spray - A liquid minutely divided as by a jet of air or steam.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Helps relieve the local itching and discomfort associated with anorectal disorders or inflammation.

Regulatory & Marketing

Labeler Name
Derma Care Research Labs
Product Type
Human Otc Drug
FDA Application #
M015
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
02-24-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72839-263-05 identifies a specific commercial package of 142 g in 1 can of Dch Rapid Relief Hemorrhoidal, a human over the counter drug labeled by Derma Care Research Labs. This spray is formulated for topical use and contains lidocaine; phenylephrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Derma Care Research Labs on February 24, 2023. The current certification is valid through December 31, 2026.

How is this Derma Care Research Labs product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72839026305. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72839-263-05
11-Digit CMS (5-4-2)
72839-0263-05

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.